**Abstract**

The follow-up of patients after coronary artery bypass grafting is of paramount importance for a good control of chronic ischemic coronary disease. The non-pharmacological treatment should be approached in an assertive way with the patients, placing it at the center of the problem participating in the health process and definitely understanding the disease. Pharmacological clinical treatment involves modern drugs, widely studied, tested and available worldwide, which need to be used at the maximum tolerated dose in order to achieve the goals disseminated by the guidelines with a view to improving morbidity and mortality and quality of life of patients.

**Keywords:** by-pass, follow-up, treatment, goals, morbity, mortality
